Medicines
Discover all available medicines and treatments
Discover all available medicines and treatments
Brand: Amicar
Aminocaproic acid is an antifibrinolytic agent that inhibits plasminogen activation and plasmin activity, thereby preventing the breakdown of fibrin clots. It is classified as a lysine analog and is used to control excessive bleeding in various clinical situations.
Used to control excessive bleeding in various clinical situations, including after surgery, trauma, and in certain medical conditions.
Outcome:
Increased risk of thrombosis
Mechanism:
Additive procoagulant effects
Outcome:
Additive antifibrinolytic effects
Mechanism:
Synergistic action
Outcome:
Potential decreased efficacy of aminocaproic acid
Mechanism:
Vitamin K's role in coagulation
Most likely new formulation: Extended-release oral formulation (Year: 2026, 60% confidence)
Based on current usage trends and clinical trial data, there is a low probability of any major regulatory changes for aminocaproic acid in the next 5 years.
Antifibrinolytic, Hemostatic Agent
Lysine Analog